SI2092935T1 - Farmacevtski sestavek za zdravljenje astme - Google Patents

Farmacevtski sestavek za zdravljenje astme

Info

Publication number
SI2092935T1
SI2092935T1 SI200230943T SI200230943T SI2092935T1 SI 2092935 T1 SI2092935 T1 SI 2092935T1 SI 200230943 T SI200230943 T SI 200230943T SI 200230943 T SI200230943 T SI 200230943T SI 2092935 T1 SI2092935 T1 SI 2092935T1
Authority
SI
Slovenia
Prior art keywords
asthma
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SI200230943T
Other languages
English (en)
Inventor
Joel A Sequeira
Stefan A Sharpe
John L Hart
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2092935(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SI2092935T1 publication Critical patent/SI2092935T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
SI200230943T 2001-08-28 2002-08-27 Farmacevtski sestavek za zdravljenje astme SI2092935T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31538601P 2001-08-28 2001-08-28
EP09006110A EP2092935B1 (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Publications (1)

Publication Number Publication Date
SI2092935T1 true SI2092935T1 (sl) 2011-07-29

Family

ID=23224164

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200230943T SI2092935T1 (sl) 2001-08-28 2002-08-27 Farmacevtski sestavek za zdravljenje astme
SI200230839T SI1420759T1 (sl) 2001-08-28 2002-08-27 Farmacevtski sestavki za zdravljenje astme

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200230839T SI1420759T1 (sl) 2001-08-28 2002-08-27 Farmacevtski sestavki za zdravljenje astme

Country Status (27)

Country Link
US (3) US20030114428A1 (sl)
EP (3) EP2092935B1 (sl)
JP (3) JP2005502675A (sl)
KR (1) KR100970531B1 (sl)
CN (2) CN1649568B (sl)
AR (1) AR036358A1 (sl)
AT (2) ATE503461T1 (sl)
AU (1) AU2002313828B2 (sl)
BR (1) BR0212089A (sl)
CA (1) CA2457926A1 (sl)
CO (1) CO5560551A2 (sl)
CY (2) CY1109212T1 (sl)
DE (2) DE60232251D1 (sl)
DK (2) DK1420759T3 (sl)
ES (3) ES2325316T3 (sl)
HK (3) HK1060972A1 (sl)
HU (1) HUP0401514A3 (sl)
MX (1) MXPA04001875A (sl)
NO (1) NO20041277L (sl)
NZ (1) NZ530987A (sl)
PE (1) PE20030390A1 (sl)
PL (1) PL209640B1 (sl)
PT (2) PT1420759E (sl)
SI (2) SI2092935T1 (sl)
TW (1) TWI324934B (sl)
WO (1) WO2003020253A2 (sl)
ZA (1) ZA200401419B (sl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
DE50211045D1 (de) * 2001-03-30 2007-11-22 Jagotec Ag Medizinische aerosolformulierungen
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ES2281691T3 (es) * 2002-08-23 2007-10-01 Schering Corporation Composiciones farmaceuticas.
EP1785156B1 (en) * 2002-08-23 2012-06-27 Schering Corporation Metered dose inhaler containing an aerosol suspension formulation
AU2003265639A1 (en) * 2002-08-27 2004-03-19 Schering Corporation Process for producing metered dose inhaler formulations
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
ES2340777T3 (es) * 2004-01-21 2010-06-09 Schering Corporation Metodo de tratamiento de la rinosinusitis aguda.
US20110053999A1 (en) * 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
ES2317306T3 (es) * 2004-10-12 2009-04-16 Generics (Uk) Limited Procedimiento para la preparacion de formulaciones en aerosol en suspension, en el que las particulas se forman por precipitacion dentro de un frasco de aerosol.
EP2484382A1 (en) 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
WO2007095039A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
WO2008097233A1 (en) * 2007-02-09 2008-08-14 Schering Corporation Stable pharmaceutical drug aerosols
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2244692A2 (en) * 2008-01-10 2010-11-03 Schering Corporation Inhalation drug products, systems and uses
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US9463161B2 (en) * 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
JP5715640B2 (ja) 2009-11-25 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
AU2010328375B2 (en) 2009-12-07 2015-08-27 Raptor Therapeutics Inc. 4-methylpyrazole formulations
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
WO2011101828A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
SI2765994T1 (sl) * 2011-10-11 2019-02-28 Chiesi Farmaceutici S.P.A. Kristalni mikrodelci beta-agonista, obloženi z maščobno kislino
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
BR112016023932B1 (pt) 2014-05-07 2022-11-29 Boehringer Ingelheim International Gmbh Nebulizador
AU2015284195B2 (en) 2014-06-30 2019-01-24 Proveris Scientific Corporation Sampling apparatus for determining the amount and uniformity of a delivered dose of drug related methods
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3383366B1 (en) 2015-12-04 2020-03-25 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CA3016890A1 (en) 2016-03-09 2017-09-14 Proveris Scientific Corporation Methods for measuring dose content uniformity performance of inhaler and nasal devices
CN106619658B (zh) * 2016-12-28 2022-02-08 四川普锐特药业有限公司 一种医用气溶胶制剂及定量吸入气雾剂
US20210338626A1 (en) 2020-04-28 2021-11-04 Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch Methods for treating or preventing a viral infection or inhibiting viral replication

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ATE134509T1 (de) * 1991-06-10 1996-03-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
NZ298169A (en) * 1994-12-22 1999-09-29 Astra Ab Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
CA2263905C (en) * 1996-08-29 2002-05-14 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
JP3840515B2 (ja) * 1998-11-26 2006-11-01 ブリタニア・ファーマスーティカルズ・リミテッド 界面活性リン脂質を含む抗喘息の組合せ
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
JP2003535042A (ja) * 2000-01-20 2003-11-25 バジリア ファルマスーチカ アーゲー 鼻腔に投与可能な環式ペプチド組成物
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme

Also Published As

Publication number Publication date
JP2010138184A (ja) 2010-06-24
US20050147565A1 (en) 2005-07-07
WO2003020253A2 (en) 2003-03-13
BR0212089A (pt) 2004-08-03
EP2092935A1 (en) 2009-08-26
CN101856362A (zh) 2010-10-13
MXPA04001875A (es) 2004-06-15
EP2319494B1 (en) 2012-06-13
PL209640B1 (pl) 2011-09-30
EP1420759B1 (en) 2009-05-06
CN1649568B (zh) 2010-10-27
CN1649568A (zh) 2005-08-03
ATE430555T1 (de) 2009-05-15
ES2389480T3 (es) 2012-10-26
HK1151987A1 (en) 2012-02-17
KR20040031002A (ko) 2004-04-09
CA2457926A1 (en) 2003-03-13
ATE503461T1 (de) 2011-04-15
PE20030390A1 (es) 2003-04-24
HK1060972A1 (en) 2004-09-03
ES2325316T3 (es) 2009-09-01
DK1420759T3 (da) 2009-08-03
ES2361805T3 (es) 2011-06-22
EP2092935B1 (en) 2011-03-30
DK2092935T3 (da) 2011-07-18
AR036358A1 (es) 2004-09-01
AU2002313828B2 (en) 2005-09-08
ZA200401419B (en) 2005-01-26
KR100970531B1 (ko) 2010-07-16
CY1109212T1 (el) 2014-07-02
HUP0401514A3 (en) 2012-08-28
PT1420759E (pt) 2009-06-30
TWI324934B (en) 2010-05-21
EP2319494A1 (en) 2011-05-11
DE60239648D1 (de) 2011-05-12
US20030114428A1 (en) 2003-06-19
DE60232251D1 (de) 2009-06-18
JP5170789B2 (ja) 2013-03-27
HUP0401514A2 (hu) 2004-12-28
JP2005502675A (ja) 2005-01-27
JP2009185075A (ja) 2009-08-20
US20100143269A1 (en) 2010-06-10
HK1128428A1 (en) 2009-10-30
SI1420759T1 (sl) 2009-10-31
NO20041277L (no) 2004-03-26
PT2092935E (pt) 2011-05-31
WO2003020253A3 (en) 2003-05-22
EP1420759A2 (en) 2004-05-26
NZ530987A (en) 2006-08-31
PL368897A1 (en) 2005-04-04
CY1111726T1 (el) 2015-10-07
CO5560551A2 (es) 2005-09-30

Similar Documents

Publication Publication Date Title
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
IL160187A0 (en) Aerosolized decongestants for the treatment of sinusitis
HUP0600781A2 (en) Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing them
HUP0200493A2 (en) Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
EP1407785A4 (en) MEDICAL COMPOSITIONS
HK1065944A1 (en) Medicinal compositions
IL161070A0 (en) Compositions for the treatment of infectious diseases
GB0111597D0 (en) Pharmaceutical compositions
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
HUP0401042A3 (en) Pharmaceutical compositions suitable for treating primary insomnia
AU2002365093A8 (en) Therapeutic compositions
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
GB0104752D0 (en) Pharmaceutical compositions
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
GB0109428D0 (en) Therapeutic compositions
HUP0200253A3 (en) Pharmaceutical compositions for combination therapy
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB2382302B (en) Pharmaceutical compositions
EP1413314A4 (en) MEDICAL COMPOSITIONS
HU0104528D0 (en) Process for the preparation and use of biocide compositions
GB0123063D0 (en) Compositions for therapy